Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
454
datasets available to search
ShareScore release 0.9.0
Dataset results
454 results for “Tamoxifen”
ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 850K]
GEO Series GSE132616. Homo sapiens. 2 samples. Type: Methylation profiling by array.
Gene expression profiling of invasive breast cancer events from the tamoxifen prevention trial
GEO Series GSE12665. Homo sapiens. 108 samples. Type: Expression profiling by array.
Comparative cistromics reveals genomic crosstalk between FOXA1 and ERα in tamoxifen-associated endometrial carcinomas
GEO Series GSE81213. Homo sapiens. 23 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Genome wide analysis of transcripts regulated by PAX2 and Tamoxifen in MCF-7 cells
GEO Series GSE139928. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and Tamoxifen
ClinicalTrials.gov study NCT01223833. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
ClinicalTrials.gov study NCT01155063. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Use of Tamoxifen in Systemic Mastocytosis
ClinicalTrials.gov study NCT01334996. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
ClinicalTrials.gov study NCT04740697. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer
ClinicalTrials.gov study NCT00002579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamoxifen Citrate in Patients With Breast Cancer
ClinicalTrials.gov study NCT00963209. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients
ClinicalTrials.gov study NCT00815555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer
ClinicalTrials.gov study NCT00899197. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients
ClinicalTrials.gov study NCT00206492. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CYP2D6 Genotype on the Clinical Effect of Tamoxifen
ClinicalTrials.gov study NCT00973037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
ClinicalTrials.gov study NCT06184750. IPD Sharing: YES. Countries: 1. Publications: 0.
Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.
ClinicalTrials.gov study NCT07289035. IPD Sharing: NO. Countries: 1. Publications: 0.
Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk
ClinicalTrials.gov study NCT04570956. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
ClinicalTrials.gov study NCT03351062. IPD Sharing: NO. Countries: 1. Publications: 0.
The Ultrasound Study of Tamoxifen
ClinicalTrials.gov study NCT01582074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clomiphene Citrate Versus Tamoxifen for Ovulation Induction in PCOs
ClinicalTrials.gov study NCT02479256. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.